grow
understand
differ
syndrom
defi
nite
case
possibl
associ
viral
infect
hepat
c
virusassoci
mix
cryoglobulinemia
hepat
b
virusassoci
polyarter
nodosa
exampl
vascul
defi
nite
viral
associ
howev
variou
type
cutan
vascul
exampl
vascul
possibl
associ
viral
infect
link
viral
infect
differ
vasculit
syndrom
subject
discuss
number
year
type
vascul
viral
infect
thought
caus
diseas
wherea
other
may
consid
trigger
immunolog
process
vascul
follow
mainten
diseas
process
factor
howev
vasculit
condit
thought
link
viral
infect
similar
viral
ill
respect
age
time
onset
diseas
even
though
defi
nite
organ
identifi
ed
articl
discuss
current
knowledg
regard
etiolog
epidemiolog
patholog
possibl
treatment
viralinduc
vascul
hepat
c
virusassoci
cryoglobulinemia
cryoglobulinemia
cg
disord
present
variabl
sever
rang
asymptomat
detect
cryoglobulin
peripher
blood
sever
case
lifethreaten
multiorgan
smallvessel
vascul
symptomat
case
cg
usual
present
weak
arthralgia
purpura
laboratori
fi
nding
includ
presenc
serum
cryoglobulin
rheumatoid
factor
hypocomplementemia
cryoglobulin
observ
varieti
condit
malign
autoimmun
diseas
infect
viral
etiolog
cg
suspect
long
time
clear
evid
associ
hepat
c
viru
hcv
infect
describ
essenti
mix
caus
identifi
ed
cg
case
believ
caus
hcv
infect
six
type
hcv
genotyp
studi
hcv
patient
cg
identifi
ed
case
asymptomat
cg
present
cg
symptom
main
risk
factor
cg
symptom
studi
genotyp
hcv
appear
support
previou
fi
nding
gad
et
al
compar
cohort
hcv
patient
egypt
genotyp
predomin
hcv
genotyp
egypt
anoth
japan
genotyp
predomin
genotyp
japan
found
japanes
patient
signifi
cantli
higher
preval
cryoglobulin
symptomat
cg
cryoglobulin
develop
hcvinfect
patient
result
virushost
interact
expans
rheumatoid
factor
synthes
b
cell
histolog
hallmark
hcvassoci
cg
evid
recent
studi
show
high
intrahepat
viral
load
correl
well
bcell
clonal
expans
particular
bcell
fraction
liver
studi
shown
signific
enrich
hcv
rna
peripher
blood
lymphocyt
mix
cg
patient
compar
nonmix
cg
group
although
exact
mechan
enrich
mix
cg
group
patient
yet
clearli
understood
hiv
infect
implic
etiolog
cg
studi
clinic
characterist
hivassoci
cg
saadoud
et
al
compar
hivhcvcoinfect
patient
mix
cg
vascul
hcvinfect
patient
mix
cg
vascul
found
group
similar
clinic
manifest
cg
vascul
includ
polyneuropathi
purpura
arthralgia
kidney
involv
howev
also
found
hivhcvcoinfect
group
signifi
cantli
lower
level
cryoglobulin
blood
ramoscas
et
al
found
patient
hivhcv
coinfect
signifi
cantli
lower
preval
cryoglobulinem
vasculit
symptom
compar
patient
hcv
monoinfect
conclud
coinfect
hiv
attenu
symptomat
express
cg
hcvassoci
vascul
howev
specifi
c
subset
hivhcv
cg
patient
high
viral
load
virus
signifi
cantli
higher
frequenc
symptomat
cg
differ
preval
cg
symptom
group
may
simpli
due
differenti
hcv
genotyp
differ
group
strong
evid
link
hcv
genotyp
cg
symptom
alreadi
shown
howev
factor
may
also
play
role
geograph
factor
may
contribut
vari
express
rheumatolog
condit
includ
vascul
cg
hiv
hcv
viral
infect
zhang
et
al
studi
consecut
inpati
hiv
infect
china
found
rheumatolog
manifest
unlik
studi
geograph
area
vascul
common
fi
nding
case
includ
case
behcetslik
diseas
case
henochschonlein
purpura
hsp
digit
gangren
one
case
central
nervou
system
vascul
studi
tcell
deplet
erythrocyt
sediment
rate
hcv
coinfect
predispos
factor
hiv
patient
develop
rheumatolog
manifest
clear
whether
cryoglobulin
test
patient
especi
patient
hsp
digit
infarct
present
treatment
hcvassoci
cg
depend
sever
present
low
dose
steroid
may
suffi
cient
control
symptom
arthralgia
weak
purpura
sever
case
especi
signifi
cant
renal
involv
present
aim
treatment
suppress
viral
replic
elimin
circul
immun
complex
use
combin
standard
interferon
alpha
ribavirin
success
halt
viral
replic
process
suppress
diseas
manifest
although
recurr
symptom
also
high
medic
use
pegyl
interferon
ribavirin
shown
better
result
standard
interferon
ribavirin
cacoub
et
al
shown
seri
nine
patient
treat
pegyl
interferon
ribavirin
patient
achiev
complet
clinic
respons
correl
erad
hcv
treatment
durat
seri
shorter
previous
report
standard
interferon
plu
ribavirin
sansonno
et
al
observ
complet
clinic
respons
monoclon
antibodi
rituximab
patient
treat
mix
cg
vascul
patient
present
sever
diseas
acut
nephrit
syndrom
aggress
approach
use
puls
corticosteroid
cyclophosphamid
plasmapheresi
recommend
relaps
mix
cg
vascul
known
occur
patient
hcv
infect
despit
achiev
sustain
viral
respons
relaps
usual
short
live
may
trigger
withdraw
interferon
alpha
therapi
howev
patient
persist
symptom
mix
cg
vascul
differ
underli
condit
must
consid
look
especi
bcell
lymphoma
hepat
b
viru
hbv
associ
vascul
immunolog
mediat
disord
clinic
manifest
ident
polyarter
nodosa
sever
multisystem
diseas
posit
serum
hepat
b
surfac
antigen
biopsi
affect
organ
show
microaneurysm
corkscrew
mediums
arteri
especi
renal
mesenter
system
hbvassoci
vascul
thought
complic
acut
hbv
infect
character
format
immun
complex
contain
hb
surfac
antigen
antihb
surfac
antibodi
basement
membran
involv
arteri
highest
annual
incid
hbvassoci
vascul
world
report
earli
alaska
rate
case
per
million
peopl
mass
vaccin
suscept
peopl
conduct
result
signifi
cant
reduct
incid
symptomat
hbv
infect
almost
complet
disappear
hbvassoci
vascul
alaskan
nativ
chronic
infect
hbv
followedup
twice
yearli
sinc
new
case
hbvassoci
vascul
identifi
ed
sinc
support
theori
hbvassoci
vascul
complic
acut
infect
mass
vaccin
prevent
new
case
occur
eight
genotyp
hbv
identifi
ed
b
c
e
f
g
h
identifi
specifi
c
hbv
genotyp
highest
associ
vascul
hurlburt
et
al
conduct
studi
compar
case
hbvassoci
vascul
hbvinfect
control
without
vascul
show
hbv
genotyp
common
hbvassoci
vascul
patient
control
odd
ratio
result
statist
signifi
cant
p
author
conclud
hbvassoci
vascul
clearli
associ
hbv
genotyp
establish
link
hbv
infect
treatment
vascul
patient
includ
use
steroid
without
cyclophosphamid
depend
sever
present
sinc
treatment
polyarter
nodosa
patient
hbv
marker
use
short
cours
steroid
suppress
infl
ammat
combin
use
antivir
agent
vidarabin
interferon
alpha
lamivudin
control
viral
replic
achiev
hb
e
antigen
hb
e
antibodi
seroconvers
use
plasma
exchang
clear
circul
immun
complex
guillevin
et
al
shown
relaps
rate
vascul
among
patient
achiev
hb
e
antigen
hb
e
antibodi
seroconvers
protocol
use
short
cours
steroid
antivir
agent
plasma
exchang
overal
surviv
rate
case
cutan
vascul
strong
associ
infect
organ
viral
infect
contribut
signifi
cant
proport
major
form
viralinduc
cutan
vascul
benign
selflimit
cours
associ
system
multiorgan
involv
variabl
sever
prognosi
viral
hepat
common
caus
cutan
vascul
eight
percent
leukocytoclast
vascul
lcv
case
associ
hcv
infect
hcvinfect
patient
develop
lcv
usual
associ
cg
although
lcv
also
report
absenc
cg
complet
tetrad
organ
involv
hsp
includ
skin
joint
gastrointestin
tract
kidney
purpura
univers
hsp
preced
viral
bacteri
upper
respiratori
tract
infect
occur
case
major
case
cutan
leukocytoclast
angiiti
cla
caus
identifi
abl
case
viral
upper
respiratori
tract
infect
implic
skin
histolog
infectiontrigg
cla
like
show
greater
frequenc
intraepiderm
epiderm
neutrophil
pustul
tissu
neutrophilia
promin
iga
vascular
deposit
rel
less
eosinophil
lymphocyt
compar
druginduc
case
cla
import
exclud
system
vascul
patient
present
cutan
vascul
consid
possibl
selflimit
viralinduc
cla
histolog
clue
sometim
exist
implic
system
vascul
palisad
neutrophil
granulomat
dermat
eg
churgstrauss
syndrom
case
system
benign
viralinduc
selflimit
cla
manifest
skin
palpabl
purpura
ident
skin
histolog
care
correl
histori
physic
examin
laboratori
fi
nding
requir
differenti
local
cutan
diseas
system
multiorgan
vascul
kawasaki
diseas
kd
acut
multisystem
vascul
unknown
etiolog
affect
mainli
young
children
clinic
epidemiolog
studi
suggest
kd
close
relat
infecti
diseas
kd
rare
children
month
year
age
condit
present
acut
onset
selflimit
cours
often
occur
cluster
case
would
suggest
condit
close
relat
possibl
viral
infect
epsteinbarr
viru
known
preval
age
group
affect
kd
howev
lee
et
al
studi
link
epsteinbarr
viru
kd
conclud
specifi
c
associ
two
condit
similarli
blind
casecontrol
studi
ascertain
relationship
human
corona
viru
kd
fail
demonstr
associ
rowley
et
al
describ
identifi
cation
cytoplasm
inclus
bodi
ciliat
bronchial
epithelium
acut
kd
patient
iga
plasma
cell
infi
ltrate
infl
ame
coronari
arteri
wall
kd
iga
plasma
cell
also
present
upper
respiratori
tract
similar
pattern
seen
sever
viral
infect
respiratori
syncyti
infl
uenza
viru
infect
iga
plasma
cell
infi
ltration
kd
suggest
immun
respons
intracellular
pathogen
respiratori
portal
entri
studi
antigen
cytoplasm
inclus
bodi
suggest
presenc
protein
nucleic
acid
within
inclus
structur
resembl
bacteri
fungal
parasit
element
observ
studi
conclud
inclus
bodi
consist
aggreg
viral
protein
associ
nucleic
acid
observ
provid
good
direct
futur
studi
etiolog
kd
varicella
zoster
viru
vzv
vasculopathi
increasingli
report
central
nervou
system
vasculitisvasculopathi
occur
secondari
vzv
infect
present
typic
rash
central
nervou
system
vascular
event
presenc
cerebrospin
fl
uid
pleocytosi
nagel
et
al
review
case
vzv
vasculopathi
found
case
vzv
igg
antibodi
cerebrospin
fl
uid
wherea
case
posit
polymeras
chain
reaction
test
vzv
dna
cerebrospin
fl
uid
conclud
test
cerebrospin
fl
uid
vzv
igg
antibodi
ideal
screen
investig
vzv
vasculopathi
also
suggest
test
case
central
nervou
system
vascul
unknown
etiolog
evid
associ
viral
infect
certain
type
vascul
increas
associ
seem
strongest
condit
like
hcvassoci
mix
cg
hbvassoci
polyarter
nodosa
associ
specifi
c
viru
genotyp
symptomat
diseas
genotyp
hcv
genotyp
hbv
explain
extent
specifi
c
subgroup
hcvinfect
patient
develop
cg
specifi
c
subset
hbvinfect
patient
develop
polyarter
nodosa
research
ongo
identifi
viral
infect
associ
vasculit
condit
kd
improv
prognosi
condit
futur
develop
target
treatment
possibl
prevent
measur
effect
seen
mass
vaccin
hbv
incid
hbvassoci
polyarter
nodosa
potenti
confl
ict
interest
relev
articl
report
